Economic Evaluation in Genomic and Precision Medicine
Autor: | Christina Mitropoulou, Sarah Wordsworth, James Buchanan, George P. Patrinos |
---|---|
EAN: | 9780128133941 |
eBook Format: | ePUB/PDF |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 19.04.2023 |
Kategorie: | |
Schlagworte: | clinical decision drug evaluation genetics genome-guided treatment genomic medicine genomics genomic trial designs health healthcare costs health t medical practice personalized medicine policy precision medicine rare diseases welfare |
109,00 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
Economic Evaluation in Genomic and Precision Medicine provides an in-depth examination of essential concepts, protocols and applications of economic evaluation in genomic and precision medicine. Contributions from leading international medical geneticists and health economists compile new ways to effectively assess the costs and outcomes of different genomic care pathways, implement cost-effective medical interventions, and enhance the value of genomic and precision healthcare. Foundational chapters and discipline-specific case studies cover topics ranging from the economic analysis of genomic trial design, to health technology assessment of next-generation sequencing, ethical aspects, economic policy in genomic medicine, and pricing and reimbursement in clinical genomics. - Introduces clinicians, researchers and students to essential concepts, protocols and applications of economic evaluation in genomic and precision medicine - Demonstrates, through foundational chapters and discipline-specific case studies, how to assess the relative costs and outcomes of different genomic care pathways and implement cost-effective budgets - Establishes clear precedents on how genomic technologies can be leveraged to simultaneously reduce costs and enhance the value of healthcare - Features contributions from leading international medical geneticists and health economists that are actively evolved in economic assessments of genomic and precision medicine